Literature DB >> 33190920

Prostatic stromal proliferations: a review.

David G Bostwick1, Lars Egevad2.   

Abstract

Prostatic stromal proliferations account for the majority of benign tumour-like lesions in the prostate. The most common is nodular hyperplasia, seen in a majority of elderly men. Diagnostic difficulty is encountered with some variants, including stromal hyperplasia with atypia, characterised by degenerative changes of myofibroblasts. In contrast with benign stromal tumours, malignant stromal tumours of the prostate are rare, accounting for less than 0.1% of all prostatic malignancies. The most common are rhabdomyosarcoma (paediatric) and leiomyosarcoma (adults); others include phyllodes tumour and stromal sarcoma. Some authors lump malignant tumours with poor outcome (e.g., phyllodes tumour and stromal sarcoma) with benign stromal tumours (e.g., stromal hyperplasia with atypia, leiomyoma), considering them collectively to be of uncertain malignant potential, but this approach is discouraged. This review presents a contemporary approach to classification and diagnosis of prostatic stromal tumours.
Copyright © 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prostate; nodular hyperplasia; pathology; phyllodes tumour; stromal sarcoma

Year:  2020        PMID: 33190920     DOI: 10.1016/j.pathol.2020.09.017

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  2 in total

1.  Clinicopathologic features and proposed grossing protocol of orchiectomy specimens performed for gender affirmation surgery.

Authors:  Kristine M Cornejo; Esther Oliva; Rory Crotty; Peter M Sadow; Kyle Devins; Anton Wintner; Chin-Lee Wu
Journal:  Hum Pathol       Date:  2022-06-02       Impact factor: 3.526

2.  Detection of relatively poor but definitive blood supply in prostate stromal sarcoma using transrectal ultrasonography with superb microvascular imaging.

Authors:  Munehiro Ohashi; Takumi Shiraishi; Atsuko Fujihara; Takeshi Yamada; Takashi Ueda; Fumiya Hongo; Osamu Ukimura
Journal:  Int Cancer Conf J       Date:  2022-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.